Dorsey Wright & Associates’s Inogen INGN Stock Holding History

Dorsey Wright & Associates’s Portfolio INGN Stock Details INGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-170	Closed	-$42K	–	312
2018 Q3	$42K	Buy	+170	New	+$39.3K	0.01%	122

Other funds holding INGN

NHAS

Novo Holdings A/S Hellerup, Denmark $1.23B AUM 81.32% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

BCM

Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

FAM

Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return

Dorsey Wright & Associates's INGN Position: Q4 2018 in Review

Dorsey Wright & Associates sold out of Inogen (INGN) in Q4 2018, closing a stake of 170 shares — an estimated $42K sold.

Dorsey Wright & Associates first reported a position in INGN in Q3 2018 and held it in 1 quarter. The position peaked at $42K in Q3 2018. 271 funds tracked by Wall St. Rank hold INGN as of Q4 2018.

Dorsey Wright & Associates reported no remaining Inogen position as of Q4 2018 after selling out during the quarter.
Dorsey Wright & Associates sold 170 Inogen shares in Q4 2018, an estimated $42K.
Dorsey Wright & Associates first reported a position in Inogen in Q3 2018 and held it in 1 quarter.
Dorsey Wright & Associates's Inogen position peaked at $42K in Q3 2018.
271 funds tracked by Wall St. Rank held Inogen as of Q4 2018.

Based on Dorsey Wright & Associates's 13F filing for Q4 2018, filed 7 Jan 2019.